Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in US

As per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nMBw58S
via IFTTT